Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 08 2023
Historique:
received: 17 11 2022
accepted: 26 07 2023
medline: 14 8 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Cells often alter metabolic strategies under nutrient-deprived conditions to support their survival and growth. Characterizing metabolic reprogramming in the tumor microenvironment (TME) is of emerging importance in cancer research and patient care. However, recent technologies only measure a subset of metabolites and cannot provide in situ measurements. Computational methods such as flux balance analysis (FBA) have been developed to estimate metabolic flux from bulk RNA-seq data and can potentially be extended to single-cell RNA-seq (scRNA-seq) data. However, it is unclear how reliable current methods are, particularly in TME characterization. Here, we present a computational framework METAFlux (METAbolic Flux balance analysis) to infer metabolic fluxes from bulk or single-cell transcriptomic data. Large-scale experiments using cell-lines, the cancer genome atlas (TCGA), and scRNA-seq data obtained from diverse cancer and immunotherapeutic contexts, including CAR-NK cell therapy, have validated METAFlux's capability to characterize metabolic heterogeneity and metabolic interaction amongst cell types.

Identifiants

pubmed: 37573313
doi: 10.1038/s41467-023-40457-w
pii: 10.1038/s41467-023-40457-w
pmc: PMC10423258
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4883

Informations de copyright

© 2023. Springer Nature Limited.

Références

PLoS Comput Biol. 2012;8(5):e1002518
pubmed: 22615553
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
Sci Adv. 2019 Jan 02;5(1):eaau7314
pubmed: 30613774
Commun Biol. 2019 Nov 14;2:414
pubmed: 31754644
Cell Rep Methods. 2021 Jul 26;1(3):
pubmed: 34761247
Sci Rep. 2021 Jul 1;11(1):13637
pubmed: 34211032
Mol Syst Biol. 2014 Mar 19;10:721
pubmed: 24646661
Sci Signal. 2020 Mar 24;13(624):
pubmed: 32209698
PLoS Comput Biol. 2019 Sep 6;15(9):e1007310
pubmed: 31490922
BMC Bioinformatics. 2018 Nov 6;19(1):404
pubmed: 30400809
Genome Biol. 2019 Jun 13;20(1):121
pubmed: 31196170
Commun Biol. 2020 May 29;3(1):271
pubmed: 32472013
PLoS Comput Biol. 2021 Nov 8;17(11):e1009550
pubmed: 34748537
Nat Biotechnol. 2022 Jan;40(1):110-120
pubmed: 34489601
Sci Rep. 2017 Jan 25;7:41241
pubmed: 28120890
J Theor Biol. 2009 May 21;258(2):311-5
pubmed: 19490860
Metabolites. 2022 Jan 17;12(1):
pubmed: 35050209
Cell. 2022 Jul 21;185(15):2678-2689
pubmed: 35839759
PLoS Comput Biol. 2008 May 16;4(5):e1000082
pubmed: 18483554
Science. 2012 May 25;336(6084):1040-4
pubmed: 22628656
PLoS Comput Biol. 2014 Jan;10(1):e1003424
pubmed: 24453953
Genome Biol. 2020 May 7;21(1):107
pubmed: 32381040
BMC Syst Biol. 2012 Jun 19;6:73
pubmed: 22713172
Bioinformatics. 2017 Mar 15;33(6):893-900
pubmed: 27998937
Sci Adv. 2023 Jul 28;9(30):eadd6997
pubmed: 37494448
Bioinformatics. 2010 Dec 15;26(24):3140-2
pubmed: 21081510
Mol Biosyst. 2012 Feb;8(2):470-81
pubmed: 22041788
PLoS One. 2020 Sep 21;15(9):e0239495
pubmed: 32956417
Ann Thorac Surg. 2020 Apr;109(4):1019-1025
pubmed: 31846640
Cancers (Basel). 2020 Feb 20;12(2):
pubmed: 32093417
Science. 2020 Apr 10;368(6487):
pubmed: 32273439
Nat Commun. 2021 Nov 10;12(1):6479
pubmed: 34759281
Front Oncol. 2017 Apr 12;7:68
pubmed: 28447025
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
NPJ Precis Oncol. 2022 Jan 27;6(1):8
pubmed: 35087143
BMC Syst Biol. 2013 Oct 03;7:98
pubmed: 24088221
Nat Commun. 2020 Feb 5;11(1):737
pubmed: 32024819
Cell. 2017 Apr 06;169(2):258-272.e17
pubmed: 28388410
Genome Biol. 2010;11(4):R43
pubmed: 20398381
Metab Eng. 2004 Oct;6(4):285-93
pubmed: 15491858
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7695-700
pubmed: 15897462
Mol Syst Biol. 2017 Aug 3;13(8):935
pubmed: 28779005
PLoS Comput Biol. 2009 Aug;5(8):e1000489
pubmed: 19714220
PLoS Comput Biol. 2016 Oct 6;12(10):e1005140
pubmed: 27711110
Nat Rev Mol Cell Biol. 2020 May;21(5):268-283
pubmed: 32144406
Front Genet. 2019 Apr 05;10:317
pubmed: 31024627
Mol Syst Biol. 2010 Jul;6:390
pubmed: 20664636
Mol Cell. 2015 May 21;58(4):699-706
pubmed: 26000853
Cancer Res. 2007 Apr 1;67(7):3441-9
pubmed: 17409455
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
EJNMMI Res. 2018 Jan 18;8(1):4
pubmed: 29349517
BMC Syst Biol. 2012 Dec 06;6:150
pubmed: 23216785
Leukemia. 2018 Feb;32(2):520-531
pubmed: 28725044
Nat Biotechnol. 2008 Sep;26(9):1003-10
pubmed: 18711341
Nat Methods. 2021 Dec;18(12):1452-1456
pubmed: 34862499
Genome Biol. 2016 Feb 17;17:29
pubmed: 26887813
Nat Cancer. 2020 Dec;1(12):1176-1187
pubmed: 33884374
Cell. 2021 Aug 5;184(16):4168-4185.e21
pubmed: 34216539
Nat Commun. 2020 Mar 13;11(1):1364
pubmed: 32170086
J Biomed Inform. 2018 Nov;87:37-49
pubmed: 30244122
Front Oncol. 2020 Jul 23;10:1254
pubmed: 32793500
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Nat Rev Drug Discov. 2011 Aug 31;10(9):671-84
pubmed: 21878982
N Engl J Med. 2020 Feb 27;382(9):869-871
pubmed: 32101671
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17845-50
pubmed: 20876091
Nat Commun. 2018 Dec 14;9(1):5330
pubmed: 30552315
Nat Commun. 2019 Aug 21;10(1):3763
pubmed: 31434891
Sci Rep. 2021 Nov 18;11(1):22486
pubmed: 34795309
Cell Rep. 2017 Dec 12;21(11):3040-3048
pubmed: 29241534
Annu Rev Biomed Data Sci. 2020 Jul;3:61-87
pubmed: 34056560
Nat Biotechnol. 2010 Mar;28(3):245-8
pubmed: 20212490
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Nat Metab. 2022 Apr;4(4):435-443
pubmed: 35361954
J Hematol Oncol. 2020 Dec 4;13(1):166
pubmed: 33276803
Front Cell Dev Biol. 2021 Jan 12;8:603837
pubmed: 33511116
Cell Res. 2020 Apr;30(4):300-314
pubmed: 32132672
Mol Syst Biol. 2010 Sep 7;6:401
pubmed: 20823844
Nature. 2021 May;593(7858):282-288
pubmed: 33828302
Nat Protoc. 2021 Nov;16(11):5123-5145
pubmed: 34535790
Trends Biochem Sci. 2018 Jun;43(6):395-397
pubmed: 29656822
PLoS Comput Biol. 2019 Feb 28;15(2):e1006733
pubmed: 30818329
Mol Syst Biol. 2021 Nov;17(11):e10260
pubmed: 34709707
Brief Bioinform. 2006 Jun;7(2):140-50
pubmed: 16772264
Bioinformatics. 2011 Feb 15;27(4):541-7
pubmed: 21172910
Curr Opin Biotechnol. 2015 Aug;34:153-61
pubmed: 25617827
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Front Immunol. 2019 Sep 24;10:2278
pubmed: 31616440

Auteurs

Yuefan Huang (Y)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Department of Biostatistics & Data Science, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, 77030, USA.

Vakul Mohanty (V)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Merve Dede (M)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Kyle Tsai (K)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

May Daher (M)

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Li Li (L)

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Katayoun Rezvani (K)

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Ken Chen (K)

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. kchen3@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH